Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omnicef vs Amoxicillin Pediatric Taste Test
NCT00645125Phase 4Completed
- Sponsor
- Abbott Laboratories
- Start
- Jan 2003
- Primary completion
- Feb 2003
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of cefdinir in bacterial infection (2 arms), sponsored by Abbott Laboratories. Primary endpoint: Taste and smell acceptability assessment at 2 hours. Started Jan 2003; status: completed.
02
Drugs
cefdinir
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT00645125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00645125.